ORDA - Online Research Data Archive 
    • Login
    View Item 
    •   ORDA Home
    • University Hospitals of Derby and Burton NHS Foundation Trust
    • Division of Women's and Children's Services
    • Gynaecology
    • View Item
    •   ORDA Home
    • University Hospitals of Derby and Burton NHS Foundation Trust
    • Division of Women's and Children's Services
    • Gynaecology
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    The impact of uterine artery embolization on ovarian reserve: a systematic reviewand meta-analysis.

    Thumbnail
    Abstract
    INTRODUCTION: In the recent years, uterine artery embolisation (UAE) has been gaining increasing popularity as an effective and minimally invasive treatment for uterine fibroids. However, there has been a growing concern over the risk of unintended embolization of the utero-ovarian circulation leading to reduction of ovarian blood supply with subsequent impairment of ovarian reserve. The purpose of this study was to investigate the impact of UAE on circulating anti-Müllerian hormone (AMH) and other markers of ovarian reserve. MATERIAL AND METHODS: This meta-analysis included all published cohort, cross-sectional and case-control studies a well as randomized trials that investigated the impact of UAE on circulating AMH. Data sources included MEDLINE, EMBASE, Dynamed Plus, ScienceDirect, TRIP database, ClinicalTrials. gov and the Cochrane Library from January 2000 to June 2019. All identified articles were screened, and articles were selected based on the inclusion and exclusion criteria. AMH and other data were extracted from the eligible articles and entered into RevMan software to calculate the weighted mean difference between pre- and post-embolization values. PROSPERO registration number: CRD42017082615. RESULTS: This review included three cohort and three case-control studies (n=353). The duration of follow up after UAE ranged between three and 12 months. Overall pooled analysis of all studies showed no significant effect of UAE on serum AMH levels (weighted mean difference -0.58 ng/ml; 95% CI -1.5 to 0.36, I2 =95%). Subgroup analysis according to age of participants (under and over 40 years) and according to follow-up duration (3, 6 and 12-month) showed no significant change in post-embolization circulating AMH. Pooled analysis of serum follicle stimulating hormone (FSH) concentrations (four studies, n=248) revealed no statistically significant change after UAE (weighted mean difference 4.32; 95% CI -0.53 to 9.17; I2= 95%). Analysis of two studies (n=62) measuring antral follicle count showed a significant decline at 3-months follow up (weighted mean difference -3.28; 95% CI -5.62 to -0.93; I2 = 94%). CONCLUSIONS: Uterine artery embolization for uterine fibroids does not seem to affect ovarian reserve as measured by serum concentrations of AMH and FSH.
    URI
    https://orda.derbyhospitals.nhs.uk/handle/123456789/2076
    Collections
    • Gynaecology [49]
    Date
    2019-08
    Author
    Shamy, TE
    James, Cathryn
    Show full item record

    copyright © 2017  Derby Teaching Hospitals NHS Foundation Trust
    Contact Us | Send Feedback
    Powered by KnowledgeArc
     

     

    Browse

    All of ORDACommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    Researcher Profiles

    Researchers

    My Account

    Login

    copyright © 2017  Derby Teaching Hospitals NHS Foundation Trust
    Contact Us | Send Feedback
    Powered by KnowledgeArc